Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig04301 |
calcium homeostasis endoplasmic reticulum protein |
417 |
20 |
2.44E-32 |
61.50% |
3 |
F:nucleic acid binding; C:intracellular; P:cellular process |
|
|
contig04302 |
---NA--- |
351 |
0 |
|
|
0 |
|
|
|
contig04303 |
---NA--- |
274 |
0 |
|
|
0 |
|
|
|
contig04304 |
---NA--- |
181 |
0 |
|
|
0 |
|
|
|
contig04305 |
---NA--- |
762 |
0 |
|
|
0 |
|
|
|
contig04306 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig04307 |
chromosome 22 open reading frame 13 |
411 |
20 |
1.34E-59 |
84.05% |
2 |
F:F; P:P |
|
|
contig04308 |
frizzled homolog 3-like |
318 |
20 |
5.77E-31 |
93.30% |
11 |
F:G-protein coupled receptor activity; C:extracellular space; P:inner ear morphogenesis; P:Wnt receptor signaling pathway; P:response to drug; P:establishment of planar polarity; F:protein binding; P:neural tube closure; C:membrane attack complex; P:G-protein coupled receptor protein signaling pathway; F:non-G-protein coupled 7TM receptor activity |
|
|
contig04309 |
---NA--- |
393 |
0 |
|
|
0 |
|
|
|
contig04310 |
subfamily member 7 |
1589 |
20 |
8.70E-145 |
77.70% |
2 |
P:protein folding; F:heat shock protein binding |
|
|
contig04311 |
gem (nuclear organelle) associated protein 5 |
349 |
20 |
2.25E-54 |
86.60% |
7 |
C:cytoplasm; P:protein complex assembly; F:snRNA binding; C:spliceosomal complex; F:protein binding; C:nuclear body; P:spliceosomal snRNP assembly |
|
|
contig04312 |
jade3 protein |
362 |
1 |
8.00E-04 |
52.00% |
0 |
|
|
|
contig04313 |
---NA--- |
123 |
0 |
|
|
0 |
|
|
|
contig04314 |
dna photolyase |
932 |
20 |
3.35E-99 |
74.25% |
4 |
P:protein-chromophore linkage; P:DNA repair; F:DNA binding; F:deoxyribodipyrimidine photo-lyase activity |
EC:4.1.99.3 |
|
contig04315 |
---NA--- |
109 |
0 |
|
|
0 |
|
|
|
contig04316 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig04317 |
afg3 atpase family gene 3-like 2 |
526 |
20 |
6.24E-83 |
96.10% |
9 |
C:mitochondrial inner membrane; F:metalloendopeptidase activity; P:protein catabolic process; F:ATP binding; F:unfolded protein binding; C:integral to membrane; F:nucleoside-triphosphatase activity; P:proteolysis; F:zinc ion binding |
EC:3.4.24.0; EC:3.6.1.15 |
|
contig04318 |
---NA--- |
255 |
0 |
|
|
0 |
|
|
|
contig04319 |
---NA--- |
819 |
0 |
|
|
0 |
|
|
|
contig04320 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig04321 |
synaptosomal-associated protein 23 |
321 |
3 |
4.16E-08 |
89.00% |
0 |
|
|
|
contig04322 |
---NA--- |
267 |
0 |
|
|
0 |
|
|
|
contig04323 |
isocitrate dehydrogenase 2 (nadp+) mitochondrial |
370 |
20 |
8.90E-59 |
96.25% |
6 |
F:manganese ion binding; C:mitochondrial inner membrane; F:isocitrate dehydrogenase (NADP+) activity; F:magnesium ion binding; P:tricarboxylic acid cycle; P:glyoxylate cycle |
EC:1.1.1.42 |
|
contig04324 |
phosphoribosyl pyrophosphate synthetase 1 |
1848 |
20 |
6.19E-153 |
98.00% |
13 |
P:purine base metabolic process; C:protein complex; C:soluble fraction; P:nucleoside metabolic process; F:GDP binding; F:ATP binding; P:nervous system development; P:AMP biosynthetic process; F:magnesium ion binding; F:ribose phosphate diphosphokinase activity; P:sensory perception of sound; F:AMP binding; F:sugar binding |
EC:2.7.6.1 |
|
contig04325 |
---NA--- |
310 |
0 |
|
|
0 |
|
|
|
contig04326 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
contig04327 |
---NA--- |
281 |
0 |
|
|
0 |
|
|
|
contig04328 |
---NA--- |
329 |
0 |
|
|
0 |
|
|
|
contig04329 |
transmembrane 9 superfamily member 2 |
514 |
20 |
3.54E-88 |
95.75% |
4 |
C:extracellular space; C:integral to plasma membrane; C:endosome membrane; P:transport |
|
|
contig04330 |
wd repeat domain 1 |
758 |
20 |
1.28E-57 |
82.45% |
6 |
C:cytoplasm; C:actin filament; F:actin binding; C:plasma membrane; P:actin filament fragmentation; C:nucleus |
|
|
contig04331 |
exportin crm1 homolog |
301 |
20 |
1.89E-45 |
94.30% |
11 |
P:response to virus; F:protein transporter activity; F:RNA binding; C:annulate lamellae; P:protein export from nucleus; C:nuclear pore; F:protein binding; P:regulation of protein catabolic process; C:cytoplasm; P:protein import into nucleus, docking; P:mRNA transport |
|
|
contig04332 |
---NA--- |
199 |
0 |
|
|
0 |
|
|
|
contig04333 |
general transcription factor polypeptide 52kda |
640 |
20 |
5.44E-79 |
89.90% |
54 |
F:valine-tRNA ligase activity; C:MHC class I protein complex; P:protein amino acid glycosylation; P:protein amino acid phosphorylation; P:protein folding; F:zinc ion binding; C:actin filament; F:tumor necrosis factor receptor binding; F:steroid hormone receptor activity; P:cell adhesion; P:transcription from RNA polymerase II promoter; C:MHC class II protein complex; P:metal ion transport; C:phagocytic cup; C:PML body; ; P:regulation of small GTPase mediated signal transduction; F:ganglioside galactosyltransferase activity; P:immune response; P:cell morphogenesis; F:metal ion transmembrane transporter activity; P:phosphate transport; F:extracellular matrix structural constituent; C:extracellular space; F:protein N-terminus binding; P:androgen receptor signaling pathway; F:calcium ion binding; C:integral to membrane; P:negative regulation of transcription, DNA-dependent; C:Golgi apparatus; P:transmembrane receptor protein tyrosine kinase signaling pathway; F:RNA polymerase II transcription factor activity; C:holo TFIIH complex; C:ruffle; C:prefoldin complex; F:sequence-specific DNA binding; P:valyl-tRNA aminoacylation; P:apoptosis; F:steroid binding; C:heterochromatin; F:unfolded protein binding; F:transcription factor activity; P:cytokinesis after mitosis; F:transmembrane receptor protein tyrosine kinase activity; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; C:collagen; F:protein homodimerization activity; F:transcription factor binding; F:ATP binding; P:actin filament bundle assembly; F:androgen receptor binding; F:transcription repressor activity; P:DNA repair; F:guanyl-nucleotide exchange factor activity |
EC:6.1.1.9; EC:2.4.1.62; EC:2.7.10.1 |
|
contig04334 |
pol polyprotein |
239 |
20 |
2.05E-07 |
69.00% |
9 |
C:chromatin; F:chromatin binding; C:nucleus; F:nucleic acid binding; P:chromatin assembly or disassembly; F:zinc ion binding; F:aspartic-type endopeptidase activity; P:proteolysis; F:peptidase activity |
|
|
contig04335 |
---NA--- |
286 |
0 |
|
|
0 |
|
|
|
contig04336 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
contig04337 |
chromatin modifying protein 6 |
249 |
20 |
1.95E-10 |
91.65% |
4 |
F:protein binding; C:membrane attack complex; C:endosome membrane; P:protein transport |
|
|
contig04338 |
small subunit processome homolog |
276 |
20 |
7.97E-12 |
91.25% |
2 |
F:F; P:P |
|
|
contig04339 |
ww domain-containing binding protein 4 |
467 |
15 |
3.08E-11 |
69.27% |
4 |
F:nucleic acid binding; C:nucleus; F:zinc ion binding; F:protein binding |
|
|
contig04340 |
ubiquitin specific protease 14 |
343 |
20 |
1.29E-49 |
94.95% |
9 |
C:soluble fraction; C:synaptosome; P:synaptic transmission; P:ubiquitin-dependent protein catabolic process; F:ubiquitin thiolesterase activity; P:ubiquitin cycle; F:tRNA guanylyltransferase activity; F:cysteine-type endopeptidase activity; F:endopeptidase inhibitor activity |
EC:3.1.2.15; EC:3.4.22.0 |
|
contig04341 |
---NA--- |
491 |
0 |
|
|
0 |
|
|
|
contig04342 |
deoxycytidine kinase |
616 |
20 |
1.66E-34 |
79.40% |
4 |
F:ATP binding; F:phosphotransferase activity, alcohol group as acceptor; P:nucleobase, nucleoside, nucleotide and nucleic acid metabolic process; F:deoxycytidine kinase activity |
EC:2.7.1.0; EC:2.7.1.74 |
|
contig04343 |
hyypothetical loc100191015 |
240 |
2 |
8.28E-09 |
75.50% |
0 |
|
|
|
contig04344 |
bmi1 polycomb ring finger oncogene |
538 |
20 |
2.35E-77 |
87.00% |
21 |
P:negative regulation of transcription from RNA polymerase II promoter; F:protein binding; F:zinc ion binding; P:humoral immune response; P:transcription antitermination; C:cytoplasm; C:ubiquitin ligase complex; P:histone ubiquitination; P:brain development; C:nuclear body; F:ubiquitin-protein ligase activity; P:somatic stem cell division; P:skeletal system development; P:zinc ion transport; P:segment specification; P:positive regulation of immature T cell proliferation in the thymus; F:chromatin binding; P:positive regulation of fibroblast proliferation; P:histone acetylation; F:transcription repressor activity; P:positive regulation of B cell proliferation |
EC:6.3.2.19 |
|
contig04345 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig04346 |
translocase of inner mitochondrial membrane 8 homolog b |
667 |
20 |
6.65E-38 |
85.60% |
7 |
F:zinc ion binding; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:mitochondrial inner membrane presequence translocase complex; P:protein import into mitochondrial inner membrane; C:mitochondrial intermembrane space protein transporter complex; P:intracellular protein transmembrane transport; P:sensory perception of sound |
|
|
contig04347 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
contig04348 |
---NA--- |
293 |
0 |
|
|
0 |
|
|
|
contig04349 |
---NA--- |
438 |
0 |
|
|
0 |
|
|
|
contig04350 |
sperm associated antigen 7 |
833 |
20 |
4.62E-22 |
86.55% |
3 |
C:nucleus; F:nucleic acid binding; F:protein binding |
|
|
contig04351 |
---NA--- |
256 |
0 |
|
|
0 |
|
|
|
contig04352 |
kinectin 1 |
250 |
20 |
5.65E-26 |
68.70% |
5 |
C:endoplasmic reticulum membrane; C:integral to plasma membrane; P:microtubule-based movement; F:kinesin binding; C:membrane fraction |
|
|
contig04353 |
---NA--- |
306 |
0 |
|
|
0 |
|
|
|
contig04354 |
---NA--- |
261 |
0 |
|
|
0 |
|
|
|
contig04355 |
metaxin 2 |
610 |
20 |
1.98E-88 |
90.30% |
3 |
P:mitochondrial transport; C:mitochondrial outer membrane; P:protein transport |
|
|
contig04356 |
mps one binder kinase activator-like 3 |
331 |
20 |
7.15E-61 |
99.00% |
5 |
C:membrane; C:Golgi apparatus; F:zinc ion binding; F:protein binding; P:transport |
|
|
contig04357 |
---NA--- |
297 |
0 |
|
|
0 |
|
|
|
contig04358 |
---NA--- |
319 |
0 |
|
|
0 |
|
|
|
contig04359 |
riken cdna isoform cra_a |
247 |
20 |
6.71E-19 |
65.40% |
2 |
P:P; C:C |
|
|
contig04360 |
---NA--- |
393 |
0 |
|
|
0 |
|
|
|
contig04361 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig04362 |
member ras onocogene family |
475 |
20 |
3.35E-26 |
84.00% |
8 |
P:neurotransmitter secretion; F:GTP binding; C:intracellular; C:plasma membrane; F:transcription factor binding; P:small GTPase mediated signal transduction; P:regulation of transcription, DNA-dependent; P:protein transport |
|
|
contig04363 |
isoform cra_c |
307 |
20 |
4.35E-26 |
84.80% |
4 |
F:chaperone binding; F:ATPase activator activity; F:chaperone activator activity; C:cytoplasm |
|
|
contig04364 |
g1 to s phase transition 1 |
632 |
20 |
4.00E-95 |
98.50% |
8 |
F:GTP binding; F:DNA binding; F:protein binding; F:translation release factor activity; C:nucleus; P:translation; P:regulation of transcription, DNA-dependent; F:GTPase activity |
EC:3.6.5.3; EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.4 |
|
contig04365 |
---NA--- |
280 |
0 |
|
|
0 |
|
|
|
contig04366 |
bcl2-associated x a |
558 |
2 |
2.81E-05 |
98.50% |
5 |
P:apoptosis; P:positive regulation of apoptosis; P:positive regulation of caspase activity; P:response to cadmium ion; P:response to methylmercury |
|
|
contig04367 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
contig04368 |
---NA--- |
397 |
0 |
|
|
0 |
|
|
|
contig04369 |
---NA--- |
297 |
0 |
|
|
0 |
|
|
|
contig04370 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig04371 |
ubiquitin-conjugating enzyme e2d 3 (ubc4 5 yeast) isoform cra_a |
645 |
20 |
7.35E-47 |
96.15% |
5 |
F:protein binding; P:ubiquitin cycle; P:proteasomal ubiquitin-dependent protein catabolic process; F:ubiquitin-protein ligase activity; P:regulation of protein metabolic process |
EC:6.3.2.19 |
|
contig04372 |
unnamed protein product [Tetraodon nigroviridis] |
248 |
1 |
1.46E-11 |
72.00% |
0 |
|
|
|
contig04373 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig04374 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
contig04375 |
smith-magenis syndrome chromosome candidate 7-like |
999 |
20 |
1.55E-161 |
80.15% |
2 |
C:membrane attack complex; C:mitochondrion |
|
|
contig04376 |
---NA--- |
202 |
0 |
|
|
0 |
|
|
|
contig04377 |
---NA--- |
298 |
0 |
|
|
0 |
|
|
|
contig04378 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig04379 |
ubiquitin- containing phd and ring finger 1 |
264 |
20 |
4.01E-11 |
90.70% |
13 |
P:DNA repair; P:organ regeneration; F:zinc ion binding; P:cell cycle; P:zinc ion transport; P:regulation of transcription, DNA-dependent; F:ligase activity; F:DNA binding; F:protein binding; P:ubiquitin cycle; F:transporter activity; P:cell proliferation; C:nucleus |
|
|
contig04380 |
pax interacting (with transcription-activation domain) protein 1 |
251 |
20 |
3.42E-31 |
92.15% |
1 |
C:nucleus |
|
|
contig04381 |
ataxin 7-like 2 |
169 |
6 |
4.70E-12 |
80.50% |
3 |
F:F; P:P; C:C |
|
|
contig04382 |
---NA--- |
278 |
0 |
|
|
0 |
|
|
|
contig04383 |
uncharacterized protein c7orf57 homolog |
245 |
2 |
7.94E-28 |
70.00% |
0 |
|
|
|
contig04384 |
---NA--- |
111 |
0 |
|
|
0 |
|
|
|
contig04385 |
---NA--- |
316 |
0 |
|
|
0 |
|
|
|
contig04386 |
adaptor-related protein complex sigma 2 subunit |
284 |
20 |
1.21E-28 |
96.35% |
7 |
P:protein complex assembly; C:cytoplasmic vesicle membrane; F:protein binding; P:vesicle-mediated transport; P:intracellular protein transport; C:clathrin adaptor complex; C:trans-Golgi network |
|
|
contig04387 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig04388 |
sh3 domain ysc-like 1 |
916 |
20 |
3.01E-20 |
78.75% |
2 |
F:F; C:C |
|
|
contig04389 |
---NA--- |
333 |
0 |
|
|
0 |
|
|
|
contig04390 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig04391 |
unnamed protein product [Tetraodon nigroviridis] |
255 |
1 |
2.72E-07 |
69.00% |
0 |
|
|
|
contig04392 |
---NA--- |
647 |
0 |
|
|
0 |
|
|
|
contig04393 |
---NA--- |
464 |
0 |
|
|
0 |
|
|
|
contig04394 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig04395 |
---NA--- |
515 |
0 |
|
|
0 |
|
|
|
contig04396 |
dihydrolipoamide dehydrogenase |
723 |
20 |
3.85E-109 |
88.05% |
18 |
F:NAD or NADH binding; P:gastrulation; F:lipoamide binding; P:cell redox homeostasis; P:dihydrolipoamide metabolic process; P:sperm capacitation; P:proteolysis; P:acetyl-CoA biosynthetic process from pyruvate; C:pyruvate dehydrogenase complex; P:mitochondrial electron transport, NADH to ubiquinone; C:acrosomal matrix; C:flagellum; C:mitochondrial matrix; F:dihydrolipoyl dehydrogenase activity; P:regulation of membrane potential; F:FAD binding; P:lipoate metabolic process; P:electron transport |
EC:1.8.1.4 |
|
contig04397 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig04398 |
---NA--- |
257 |
0 |
|
|
0 |
|
|
|
contig04399 |
yy1 transcription factor |
378 |
20 |
1.97E-42 |
79.90% |
9 |
C:PcG protein complex; P:regulation of transcription from RNA polymerase II promoter; F:zinc ion binding; C:transcription factor complex; F:transcription corepressor activity; F:transcription factor activity; P:camera-type eye morphogenesis; F:transcription coactivator activity; P:anterior/posterior pattern formation |
|
|
contig04400 |
dep domain containing 7 |
602 |
20 |
3.08E-13 |
50.80% |
4 |
; F:F; P:P; C:C |
|
|
100 Rows returned.